CINECA IRIS Institutional Research Information System

RUBINI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.883
AS - Asia 1.943
EU - Europa 1.933
SA - Sud America 412
AF - Africa 53
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.239
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.657
IT - Italia 833
SG - Singapore 662
CN - Cina 610
BR - Brasile 242
ES - Italia 180
DE - Germania 151
MX - Messico 132
VN - Vietnam 126
IE - Irlanda 122
FR - Francia 108
IN - India 103
JP - Giappone 86
FI - Finlandia 82
GB - Regno Unito 82
HK - Hong Kong 72
CA - Canada 67
KR - Corea 63
SE - Svezia 58
AR - Argentina 57
BD - Bangladesh 43
NL - Olanda 36
PL - Polonia 36
RU - Federazione Russa 35
CO - Colombia 34
ID - Indonesia 34
AT - Austria 31
RO - Romania 28
TR - Turchia 28
UA - Ucraina 26
EC - Ecuador 23
TW - Taiwan 23
CH - Svizzera 18
PT - Portogallo 18
CL - Cile 17
GR - Grecia 17
IQ - Iraq 14
PE - Perù 14
EG - Egitto 13
IL - Israele 11
MA - Marocco 11
PK - Pakistan 11
AU - Australia 10
BE - Belgio 10
VE - Venezuela 10
DK - Danimarca 9
IR - Iran 9
PH - Filippine 9
CZ - Repubblica Ceca 8
BG - Bulgaria 7
CR - Costa Rica 7
HU - Ungheria 7
MT - Malta 7
DO - Repubblica Dominicana 6
DZ - Algeria 6
PY - Paraguay 6
SA - Arabia Saudita 5
SI - Slovenia 5
BO - Bolivia 4
JM - Giamaica 4
KE - Kenya 4
LT - Lituania 4
NI - Nicaragua 4
SN - Senegal 4
TH - Thailandia 4
UY - Uruguay 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
EU - Europa 3
HR - Croazia 3
JO - Giordania 3
LV - Lettonia 3
MY - Malesia 3
NO - Norvegia 3
OM - Oman 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
NP - Nepal 2
QA - Qatar 2
TN - Tunisia 2
AZ - Azerbaigian 1
BM - Bermuda 1
CG - Congo 1
CU - Cuba 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
LK - Sri Lanka 1
MN - Mongolia 1
MQ - Martinica 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
Totale 7.231
Salva come PNG Salva come JPEG
Città #
Singapore 394
Santa Clara 251
Chandler 232
Ashburn 193
Turin 157
Ann Arbor 155
Beijing 142
San Jose 138
Dublin 122
Fairfield 113
Milan 84
Torino 78
Sesto San Giovanni 75
Wilmington 64
Rome 62
Los Angeles 61
Seoul 56
Helsinki 55
Hong Kong 54
Dallas 50
Woodbridge 49
New York 48
Tokyo 47
Hefei 46
Lauterbourg 45
Medford 44
Madrid 41
Houston 40
São Paulo 40
Cambridge 39
Columbus 38
Ho Chi Minh City 37
Nyköping 37
Munich 36
Redwood City 36
Shanghai 36
Seattle 34
Bengaluru 32
Mexico City 29
The Dalles 29
Princeton 28
Jakarta 26
Hangzhou 24
Hanoi 24
Paris 21
Boardman 20
Dong Ket 20
Council Bluffs 19
Nuremberg 19
Chengdu 18
Giussano 18
Guangzhou 18
Vienna 18
Frankfurt am Main 17
Barcelona 16
San Diego 16
Bologna 15
Buenos Aires 15
Córdoba 15
Düsseldorf 14
Jacksonville 14
Redondo Beach 14
Toronto 14
Valencia 14
Wuhan 14
Buffalo 13
Dearborn 13
Washington 13
Chicago 12
Coyoacán 12
Hyderabad 12
Lima 12
Medellín 12
Orem 12
Turku 12
Ankara 11
Athens 11
Atlanta 11
Berlin 11
Chennai 11
Da Nang 11
Hebei 11
Santiago 11
Falls Church 10
Lappeenranta 10
Lisbon 10
Mumbai 10
Boston 9
Changsha 9
Guadalajara 9
Guiyang 9
Manchester 9
Naples 9
Quito 9
Santander 9
Amsterdam 8
Brasov 8
Cuenca 8
Denver 8
Mainz 8
Totale 4.133
Salva come PNG Salva come JPEG
Nome #
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome 496
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab 474
Treatment of antiphospholipid syndrome 423
Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome 320
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring 307
Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score 249
Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss 249
Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS 241
The Interconnection Between Systemic Lupus Erythematosus and Diet: Unmet Needs, Available Evidence, and Guidance—A Patient-Driven, Multistep-Approach Study 205
Reliability of lupus anticoagulant and anti-phosphatidylserine/prothrombin autoantibodies in antiphospholipid syndrome: A multicenter study 201
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 191
A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy 174
Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients 171
IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients 170
Tailoring tofacitinib oral therapy in rheumatoid arthritis: The TuTORApp—a usability study 170
Impact of the new 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a multicenter cohort study of 133 women with undifferentiated connective tissue disease 163
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis 161
Daratumumab monotherapy for refractory lupus nephritis 158
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol 158
2023 ACR/EULAR classification criteria in existing research cohorts: an international study 157
Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome 152
Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technology 150
Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies 145
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) 142
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients 140
Antiphospholipid Syndrome Is Still a Rare Disease—Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte-García et al 134
"How we treat" clinical dilemmas in antiphospholipid syndrome: A case-based approach 129
Genetic factors in antiphospholipid syndrome: Preliminary experience with whole exome sequencing 126
Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation 126
Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study 123
The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities 115
Validation of the particle-based multi-analyte technology for detection of anti-phosphatidylserine/ prothrombin antibodies 111
New Frontiers in Autoimmune Diagnostics: A Systematic Review on Saliva Testing 95
Victims of drug facilitated sexual assault aged 13-24: a cross sectional study on the pool of users of a sexual violence relief centre in Northern Italy 91
Prevalence and significance of anti-phosphatidylserine antibodies: A pooled analysis in 5992 patients 91
Serum Biomarkers of Renal Fibrosis: A Systematic Review 86
Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head 86
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) (vol 122, pg 1612, 2022) 77
Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies 75
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain 62
Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients 60
Taking care of women living with female genital mutilation or cutting: Characteristics of the pool of users of two healthcare facilities in Turin, Northern Italy 60
Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case study 57
The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes 53
Migrant survivors of conflict-related sexual violence accessing a specialist health service in Turin, Italy: a qualitative analysis of clinical forensic interview transcripts 43
Totale 7.367
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.983
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022680 40 45 54 50 73 58 60 43 50 30 79 98
2022/2023920 91 87 43 72 85 182 63 68 73 32 74 50
2023/2024870 82 84 83 49 90 79 55 68 25 75 34 146
2024/20251.461 59 81 69 122 307 118 91 89 110 114 105 196
2025/20262.482 214 133 162 306 238 148 300 117 238 145 148 333
2026/2027169 169 0 0 0 0 0 0 0 0 0 0 0
Totale 7.367